v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 3,787 $ 3,716
Increase (decrease) in cash from operating assets and liabilities:    
Accounts receivable (1,417) 320
Inventories and other assets (26) (427)
Accounts payable and accrued expenses (439) (676)
Depreciation and amortization 1,874 1,723
Income taxes 269 880
Losses (gains) on sales of facilities (9) 2
Amortization of debt issuance costs and discounts 23 25
Share-based compensation 171 197
Other 116 101
Net cash provided by operating activities 4,349 5,861
Cash flows from investing activities:    
Purchase of property and equipment (2,350) (2,167)
Acquisition of hospitals and health care entities (386) (326)
Sales of hospitals and health care entities 21 167
Change in investments (120) 41
Other (4) 2
Net cash used in investing activities (2,839) (2,283)
Cash flows from financing activities:    
Issuance of long-term debt 2,994 5,233
Net change in short-term borrowings and revolving credit facility 2,679 1,768
Repayment of long-term debt (2,608) (5,660)
Distributions to noncontrolling interests (334) (394)
Payment of debt issuance costs (17) (57)
Payment of dividends (354) (351)
Repurchase of common stock (3,635) (5,011)
Other (259) (112)
Net cash used in financing activities (1,534) (4,584)
Effect of exchange rate changes on cash and cash equivalents (3) 12
Change in cash and cash equivalents (27) (994)
Cash and cash equivalents at beginning of period 1,040 1,933
Cash and cash equivalents at end of period 1,013 939
Interest payments 1,163 1,074
Income tax payments, net $ 725 $ 146